Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome
Annals of Thoracic Surgery
© 2019 The Society of Thoracic Surgeons Angiotensin II is a novel vasopressor recently approved for the treatment of vasodilatory shock. We describe a case in which Angiotensin II was used to treat post–cardiopulmonary bypass vasoplegic syndrome in a patient who was refractory to standard vasopressors and other rescue therapies. Despite requiring high-dose vasopressors, the patient was extubated within 24 hours and has met key quality metrics defined by The Society of Thoracic Surgeons.
Evans, A., McCurdy, M., Weiner, M., Zaku, B., & Chow, J. (2019). Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome. Annals of Thoracic Surgery, 108 (1). http://dx.doi.org/10.1016/j.athoracsur.2018.11.047